M&B Engineering Files Draft Papers To Raise Up To Rs 653 Crore Via IPO
M&B Engineering Ltd. on Wednesday filed the draft red herring prospectus to raise up to Rs 653 crore through an initial public offering.
The IPO will comprise a fresh issue of up to Rs 325 crore, and an offer-for-sale component worth Rs 328 crore, as per the DRHP. The shares would be offered at a face value of Rs 10 apiece.
Through the OFS, shareholders who are part of the promoter and promoter group, would be offloading their stake. The list includes Girishbhai Manibhai Patel, who will be selling shares worth Rs 132.6 crore.
Other selling shareholders include Chirag Hasmukhbhai Patel, who will offload stake worth Rs 110 crore, followed by Birva Chirag Patel (Rs 37.5 crore), Umaben Girishbhai Patel (Rs 15 crore), Aditya Vipinbhai Patel (Rs 13 crore), Vipinbhai Kantilal Patel (Rs 12.3 crore), and Leenaben Vipinbhai Patel (Rs 7.5 crore).
M&B Engineering, in the DRHP, noted that 10% of the net offer would be reserved for retail investors. The quota of qualified institutional buyers will not exceed 75% of the overall offer, whereas the remaining 15% portion will be earmarked for non-institutional investors.
Utilisation Of Proceeds
The amount to be raised through the fresh issue of shares will be used for "funding the capital expenditure requirements for the purchase of equipment and machinery at our manufacturing facilities," M&B Engineering said.
The proceeds will also be utilised for "repayment or prepayment, in full or in part, of certain borrowings"; funding the working capital requirements; and for general corporate purposes, the DRHP added.
Notably, M&B Engineering logged a net profit of Rs 45.6 crore and a revenue from operations of Rs 795 crore in fiscal 2024. In the preceding financial year, it recorded a net profit of Rs 32.8 crore and revenue of Rs 880.4 crore.
The draft papers have been filed at a time when India's IPO market has been buzzing, with more than 235 companies raising in excess of Rs 71,000 crore in 2024 so far.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.